tiprankstipranks
Biogen (BIIB)
NASDAQ:BIIB
Holding BIIB?
Track your performance easily

Biogen (BIIB) Technical Analysis

4,584 Followers

Technical Sentiment

Overall Consensus
Sell
6Bullish
4Neutral
12Bearish
Technical Analysis Consensus
Buy
4Bullish
4Neutral
2Bearish
Moving Average Consensus
Strong Sell
2Bullish
0Neutral
10Bearish
Biogen’s (BIIB) Moving Averages Convergence Divergence (MACD) indicator is -7.44, suggesting Biogen is a Buy.
Biogen’s (BIIB) 20-Day exponential moving average is 166.85, while Biogen’s (BIIB) share price is $158.71, making it a Sell.
Biogen’s (BIIB) 50-Day exponential moving average is 178.79, while Biogen’s (BIIB) share price is $158.71, making it a Sell.

Biogen (BIIB) Pivot Points

Nov 26, 2024, 08:58 AM
Name
S3
S2
S1
Pivot Points
R1
R2
R3
Classic
154.44
155.86
156.88
158.30
159.32
160.74
161.76
Fibonacci
155.86
156.79
157.37
158.30
159.23
159.81
160.74
Pivot points are a technical analysis tool used by traders to identify potential support and resistance levels in financial markets. Pivot points are calculated based on the previous day's high, low, and close prices, and are used to help traders identify levels at which the price may reverse or continue to trend.

Biogen (BIIB) Moving Averages

Nov 26, 2024, 08:58 AM
Period
Simple
Exponential
MA5
157.21Buy
158.50Buy
MA10
160.29Sell
161.11Sell
MA20
167.96Sell
166.85Sell
MA50
181.02Sell
178.79Sell
MA100
195.72Sell
191.30Sell
MA200
207.40Sell
206.48Sell
Biogen’s (BIIB) 10-Day exponential moving average is 161.11, while Biogen’s (BIIB) share price is $158.71, making it a Sell.
Biogen’s (BIIB) 100-Day exponential moving average is 191.30, while Biogen’s (BIIB) share price is $158.71, making it a Sell.
Biogen’s (BIIB) stock price is $158.71 and Biogen’s (BIIB) 50-day simple moving average is 181.02, creating a Sell signal.
Biogen’s (BIIB) stock price is $158.71 and Biogen’s (BIIB) 100-day simple moving average is 195.72, creating a Sell signal.
Biogen’s (BIIB) stock price is $158.71 and Biogen’s (BIIB) 200-day simple moving average is 207.40, creating a Sell signal.

Biogen (BIIB) Technical Indicators

Nov 26, 2024, 08:58 AM
Name
Value
Implied Action
RSI (14)
26.74
Buy
STOCH (9,6)
20.62
Neutral
STOCHRSI (14)
17.93
Buy
MACD (12,26)
-7.44
Buy
ADX (14)
30.11
Neutral
Williams %R
-80.10
Buy
CCI (14)
-82.40
Neutral
ATR (14)
4.28
-
Ultimate Oscillator
30.96
Neutral
ROC
-10.30
Sell
Biogen’s (BIIB) Relative Strength Index (RSI) is 26.74, creating a Buy signal.
Biogen’s (BIIB) Trend Strength Indicator (ADX) is 30.11, creating a Neutral signal.
Biogen’s (BIIB) Commodity Channel Index (CCI) is -82.40, creating a Neutral signal.
Biogen’s (BIIB) Price Rate of Change (ROC) is -10.30, creating a Sell signal.

FAQ

Is BIIB a Buy, Hold, or Sell?
Based on BIIB’s technical indicators, BIIB is a Sell.
    What is BIIB’s RSI (14)?
    BIIB’s RSI (14) is 26.74, which suggests BIIB is a Buy.
      What is BIIB’s MACD?
      BIIB’s MACD is -7.44, which suggests BIIB is a Buy.
        What is BIIB’s 5-day moving average?
        BIIB’s 5-day moving average is 157.21, which suggests BIIB is a Buy.
          What is BIIB’s 20-day moving average?
          BIIB 20-day moving average is 167.96, which suggests BIIB is a Sell.
            What is BIIB’s 50-day moving average?
            BIIB’s 50-day moving average is 181.02, which suggests BIIB is a Sell.
              What is BIIB’s 200-day moving average?
              BIIB’s 200-day moving average is 207.40, which suggests BIIB is a Sell.
                What is BIIB’s Williams % R (14)?
                BIIB’s Williams % R (14) is -80.10, which suggests BIIB is a Buy.
                  What is BIIB’s CCI (14)?
                  BIIB’s CCI (14) is -82.40, which suggests BIIB is a Neutral.
                    What am I Missing?
                    Make informed decisions based on Top Analysts' activity
                    Know what industry insiders are buying
                    Get actionable alerts from top Wall Street Analysts
                    Find out before anyone else which stock is going to shoot up
                    Get powerful stock screeners & detailed portfolio analysis